Jeff Huynh

Jeff brings over 15 years of experience in medical devices, pain medicine, and neuromodulation, with a passion for transforming innovative technologies into impactful solutions that enhance patient quality of life. His expertise spans from conceptualization to regulatory approvals and global commercialization. Notable successes include the European, Australian, and U.S. commercialization of Spinal Modulation, Inc. (acquired by Abbott) and its dorsal root ganglion stimulator for chronic pain; the European and Australian launch of Saluda Medical, Inc.'s closed-loop spinal cord stimulation system; and the nationwide U.S. rollout of Nalu Medical, Inc.’s micro-IPG platform in both peripheral nerve and spinal cord stimulation markets.